WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq:INCY) announced today an update to the conference call and webcast time for its fourth quarter and year end 2017 financial results to 8:00 a.m. ET on Thursday, February 15, 2018.
The updated schedule for the press release and conference call/webcast is as follows:
|
|
||||||||
|
• |
Q4 & YE 2017 Press Release: | February 15, 2018 at 7:00 a.m. ET | ||||||
|
• |
Q4 & YE 2017 Conference Call: | February 15, 2018 at 8:00 a.m. ET | ||||||
|
• |
Domestic Dial-In Number: | 877-407-3042 | ||||||
|
• |
International Dial-In Number: | 201-389-0864 | ||||||
|
• |
Conference ID Number: | 13675376 | ||||||
If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13675376.
The live webcast with slides can be accessed at www.incyte.com under For Investors, Events and Presentations and will be available for replay for 30 days.
About Incyte
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit the Company's website at www.incyte.com.
Follow @Incyte on Twitter at https://twitter.com/Incyte.